NI
RIGL icon

Numeric Investors’s Rigel Pharmaceuticals RIGL Stock Holding History

Numeric Investors’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-84,658
Closed -$1.89M – 1173
2016
Q2 		$1.89M Sell
84,658
-50
-0.1% -$1.24K 0.02% 456
2016
Q1 		$1.76M Sell
84,708
-4,050
-5% -$99.9K 0.02% 453
2015
Q4 		$2.69M Buy
88,758
+18,489
+26% +$561K 0.03% 392
2015
Q3 		$1.74M Sell
70,269
-38,328
-35% -$1.14M 0.02% 420
2015
Q2 		$3.49M Buy
+108,597
New +$4.15M 0.04% 309
2015
Q1 		– Sell
-8,530
Closed -$194K – 1012
2014
Q4 		$194K Sell
8,530
-21,928
-72% -$443K ﹤0.01% 792
2014
Q3 		$591K Buy
30,458
+20,968
+221% +$592K 0.01% 551
2014
Q2 		$344K Buy
9,490
+1,910
+25% +$64.9K 0.01% 642
2014
Q1 		$294K Buy
7,580
+5,540
+272% +$197K 0.01% 676
2013
Q4 		$58K Buy
+2,040
New +$59.9K ﹤0.01% 758
2013
Q3 		– Sell
-9,220
Closed -$308K – 856
2013
Q2 		$308K Buy
+9,220
New +$418K 0.01% 650

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Numeric Investors's RIGL Position: Q3 2016 in Review

Numeric Investors sold out of Rigel Pharmaceuticals (RIGL) in Q3 2016, closing a stake of 84,658 shares — an estimated $1.89M sold.

Numeric Investors first reported a position in RIGL in Q2 2013 and held it in 11 quarters. The position peaked at $3.49M in Q2 2015. 121 funds tracked by Wall St. Rank hold RIGL as of Q3 2016.

  • Numeric Investors reported no remaining Rigel Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Numeric Investors sold 84,658 Rigel Pharmaceuticals shares in Q3 2016, an estimated $1.89M.
  • Numeric Investors first reported a position in Rigel Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Numeric Investors's Rigel Pharmaceuticals position peaked at $3.49M in Q2 2015.
  • 121 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2016.

Based on Numeric Investors's 13F filing for Q3 2016, filed 14 Nov 2016.